CDK2 and neoplasm: Immunohistochemistry staining of the tumor tissues showed significantly reduced expressions of Rb (Fig. 8d), CDK2 (Fig. 8e), CDK4 (Fig. 8f), and CDK6 (Fig. 8g) in vanoxerinedihydrochloride treatment group, as compared to control PBS treatment group.